Interferon associated retinopathy

British Journal of Ophthalmology

Volumn 82, Issue 3, 1998, Pages 323-325

  Hayasaka, Seiji ^a   Nagaki, Yasunori ^a   Matsumoto, Masayuki ^a   Sato, Shoichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR; SHORT SURVEY;

EID: 0031976466     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.3.323     Document Type: Short Survey

References (54)

1. Isaacs A, Lindenmann J. Virus interference. I The interferon. Proc Roy Soc B 1957;147:258-67.
2. Quesada JR, Rios A, Swanson D, Trown P, Gutterman JU. Antitumor activity of recombinant-derived interferon alfa in metastatic renal cell carcinoma. J Clin Oncol 1985;3:1522-8.
3. Sertoli MR, Bernengo MG, Ardizzoni A, et al. Phase trial of recombinant alfa-2b interferon in the treatment of metastatic skin melanoma. Oncology 1989;46:96-8.
4. Krown SE, Real FX, Krim M, et al. Recombinant leukocyte A interferon in Kaposi's sarcoma. Ann NY Acad Sci 1984;437:431-8.
5. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989; 320:1197-200.
6. Friesel R, Komoriya A, Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 1987;104:689-96.
7. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alfa-interferon. Ophthalmology 1993;100:9-14.
8. Sundmacher R, Cantell K, Skoda R, Hallermann C, Neumann-Haefekin D. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Graefes Arch Clin Exp Ophthalmol 1978; 208: 229-33.
9. Fung WE. Interferon alfa 2a for treatment of age-related macular degeneration. Am J Ophthalmol 1991;112:349-50.
10. Poliner LS, Tornambe PE, Michelson PE, Heitzmann JG. Interferon alfa-2a for subfoveal neovascularization in age-related macular degeneration. Ophthalmology 1993;100:1417-24.
11. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350-6.
12. Gillies MC, Goldberg I, Young SH, Su T. Glaucoma filtering surgery with interferon alfa 2b. J Glaucoma 1993;2:229-35.
13. Gillies M, Francis I, McClusbey P, Wakefield D. Local interferon alfa-2b for ocular cicatricial pemphigoid. Br J Ophthalmol 1996;80:927.
14. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients. A review. J Clin Oncol 1986;4:234-43.
15. Ikebe T, Nakatsuka K, Goto M, Sakai Y, Kageyama S. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn (Ganka-Kiyo) 1990;41:2291-6.
16. Isaka Y, Nishi Y, Ito Y, Seid K. Ophthalmic manifestations of interferon therapy in eight patients. Folia Ophthalmol Jpn (Ganka-kiyo) 1993;44: 1954-8.
17. Miyamoto K, Suda T, Motokura M, et al. Retinopathy in interferon-α treatment. J Eye (Atarashii Ganka) 1993;10:497-500.
18. Kado M, Yoshida A, Sakagami S. Retinopathy in patients with type C hepatitis during interferon therapy. J Jpn Ophthalmol Assoc (Nippon-no-Ganka) 1993;64:961-5.
19. Seki K, Itou Y, Nishi Y, Isaka Y. Interferon therapy for type C chronic active hepatitis and retinal hemorrhage. Kanzo 1993;34:385-91.
20. Saida H, Miyazato H, So Y, et al. Two cases of visual disturbance and fundus abnormality during interferon therapy. Rinsho-to-Kenkyu 1993;70: 2863-7.
21. Imaizumi H, Takeda M, Okushiba U, et al. Retinal vascular lesions in patients under systemic interferon therapy. Jpn J Clin Ophthalmol (Rinsho Ganka) 1994;48:171-5.
22. Futami H, Chuuman T, Naoi N, et al. Ocular complications during systemic interferon therapy. Jpn J Clin Ophthalmol (Rinsho Ganka) 1994;48:533-7.
23. Yoshitoshi T, Saegusa K, Watanabe A, et al. A case of panophthalmitis developed during interferon therapy. Jpn J Clin Ophthalmol (Rinsho Ganka) 1994;48:692-3.
24. Hagiwara M, Takahashi K, Okami T. Retinopathy associated with interferon α. Jpn J Clin Ophthalmol (Rinsho Ganka) 1994;48:1222-3.
25. Takikawa H, Kawakubo H, Yuzawa M, et al. Interferon associated retinopathy induced by interferon β. Ganka 1994;36:189-93.
26. Takamine Y, Sugino K, Kanno T, Miki T. Studies of interferon-associated retinopathy from 20 cases. J Eye (Atarashii Ganka) 1994;11:807-10.
27. Miyamura M, Arima M, Takigawa J, et al. Aggravation of diabetic retinopathy in interferon treatment. J Eye (Atarashii Ganka) 1994;11: 1065-8.
28. Kawamoto E, Hara T, Kojima T. Central retinal vein occlusion associated with interferon. J Eye (Atarashii Ganka) 1994;11:1135-41.
29. Ohuchi M, Nagamatsu R, Maeda K. Study of retinopathy in interferon therapy for type C chronic active hepatitis. J Eye (Atarashii Ganka) 1994; 11:1631-3.
30. Saitoh T, Furumoto A, Tsukamoto H. A case of retinal hemorrhage during interferon therapy. J Eye (Atarashii Ganka) 1994;11:1793-6.
31. Kubo E, Tsuzuki S, Kobayashi T, et al. Six cases of interferon-associated retinopathy. Folia Ophthalmol Jpn (Ganka-Kiyo) 1994;45:886-90.
32. Chuman T, Nao-i N, Sawada A, Kawano T, Shigehira M. Interferon-induced retinal changes. J Jpn Ophthalmol Soc (Nichigan-Kaishi) 1994;98: 616-21.
33. Sohnoh T, Takemura A, Saitoh Y, et al. Three cases of presumed interferon-associated retinopathy. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1994;88: 1069-73.
34. Ayaki M. A case of neovascular glaucoma during systemic interferon therapy. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1994;88:1527-9.
35. Kishimoto N, Arichi M, Yamada S, Shiragami S, Uehara M. Interferon-associated retinopathy in type C chronic hepatitis. Jpn J Clin Ophthalmol (Rinsho Ganka) 1995;49:155-9.
36. Harada T, Niwa T, Yamazaki S, Takeda Y, Majima Y. Four cases of retinopathy associated with interferon treatment. Ganka 1995;37:601-6.
37. Hayasaka S, Fujii M, Yamamoto Y, et al. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995;79:150-2.
38. Tadokoro Y, Ohtsuki H, Okano M, Furuse T. A case of disc edema during systemic interferon therapy. Folia Ophthalmol Jpn (Ganka-Kiyo) 1995;46: 653-6.
39. Nakamura A, Saitoh M, Mitsudome T, Kuroki K, Sawada A. Sudden visual impairment in a case under interferon therapy for type C chronic active hepatitis. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1995;89:1386-9
40. Soushi S, Kobayashi F, Obazawa H, et al. Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis. J Jpn Ophthalmol Soc (Nichigan-Kaishi) 1996;100:69-76.
41. Fujikawa Y, Fujikawa E, Hasebe S, Matsuo N. A case of recurrent branch retinal vein occlusion following systemic interferon therapy. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1996;90:157-9.
42. Hayasaka S, Okada M, Yamamoto S. Retinopathy in chronic hepatitis C patients treated by systemic interferon alfa-2b. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1996;90:1274-6.
43. Chen LL, Onishi A, Kawano C, et al. Interferon-associated retinopathy in patients receiving systemic interferon therapy. Folia Ophthalmol Jpn (Ganka-Kiyo) 1996;47:1263-8.
44. Abe T, Sakuragi S, Ono T, Komatsu M, Masamune O. Interferon-associated retionopathy in chronic hepatitis C patients. Folia Ophthalmol Jpn (Ganka-Kiyo) 1996;47:1525-32.
45. Sakai T, Nishiyama K, Okamoto S, Tobari I. Interferon-associated retinopathy in eyes with diabetic retinopathy. Jpn J Clin Ophthalmol (Rinsho Ganka) 1996;50:359-62.
46. Sugasawa K, Hagiwara M, Okami T, et al. Causative factors of interferon retinopathy. Jpn J Clin Ophthalmol (Rinsho Ganka) 1996;50:385-9.
47. Hayasaka S. Interferon-associated retinopathy. J Jpn Ophthalmologists Assoc (Nippon-no-Ganka) 1997;68: 231-3.
48. Bauherz G, Soeur M, Lustman F. Oculomotor nerve paralysis induced by alfa II-interferon. Acta Neurol Belg 1990;90:111-1.
49. Klose M, Hopf E, Bleckmann H. Untersuchungen zum Auftreten der Interferon alfa-induzierten Retinopathie. Klin Monatsbl Augenheilkd 1994;204: 199.
50. Vegh S, Vernot J, Peyman GA, Fiscella R. Toxicity of intravitreal interferon. Ophthalmic Surg 1986;17:103-5.
51. Abe T, Nakajima A, Ishikawa M, Satoh N, Sakuragi S. Effect of long-term interferon-α administration on the mouse retina. Folia Ophthalmol Jpn (Ganka-Kiyo) 1996;47:787-91.
52. Abe T, Sakuragi S, Kuramitsu T, et al. Retinopathy associated with hepatitis C virus. Jpn J Clin Ophthalmol (Rinsho Ganka) 1993;47:297-300.
53. Abe T, Jo K, Uchiyama H, et al. Induction of hepatitis-C virus-associated retinopathy following interferon administration. J Eye (Atarashii Ganka) 1993;10:1963-7.
54. Abe T, Nakajima A, Satoh N, et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol 1995;39:411-9.